Head-to-head · WeighScore
Oak vs Ro
By GLP-1 ScorecardUpdated
Score comparison
Ro has the higher recorded score — 80.2/100 to 63.2/100.
Ro grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ro is worth comparing for branded access and insurance help, but the membership price is only one part of the bill.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Oak | Ro |
|---|---|---|
| WeighScore | 63.2/100 | 80.2/100 |
| Grade | C | B− |
| Site position | #221 | #38 |
| Semaglutide | From $119/mo on a 12-month plan; quarterly or upfront billing depends on selected plan; actual dose, supply and charge unverified | Varies (branded medication plus separate membership) |
| Tirzepatide | From $185/mo on a 12-month plan; quarterly or upfront billing depends on selected plan; actual dose, supply and charge unverified | Varies (branded medication plus separate membership) |
| Coverage | Confirm selected treatment and state: homepage promotes a 50-state provider network, while terms say 45 states or certain states | Multi-state |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #221 · C
Strengths
- Current semaglutide and tirzepatide product pages explicitly identify the twelve-month term behind advertised starting rates
- Monthly and three-month plans have no cancellation fee before the next charge under the current refund section
- The policy specifies a medical-stop exception, prepaid future-month refund calculation and a limit on quarterly-plan discount repayment
- Branded pens and Oral Wegovy tablets are now advertised alongside compounded injections; availability and exact prices require confirmation
What to consider
- The $119/$185 rates do not establish a monthly debit, dose-independent price or usable shipment supply
- Leaving a six- or twelve-month quarterly plan early can repay discounts on months received, capped at one quarterly payment
- Orders already sent to the pharmacy are final; stopping the account does not refund them
- The same terms page retains inconsistent company names, membership-fee language and state-availability statements
- The public material reviewed did not establish the assigned medical practice, individual prescriber or dispensing pharmacy legal name and address
Site position #38 · B−
Strengths
- Brand-name access + insurance support
- Oral options
- Current pricing separates membership from medication charges
What to consider
- Membership starts at $39 for the first month, then $74–149 per month depending on term; the $74 rate requires annual prepayment
- Medication is extra; the total depends on the selected drug and payment arrangement
- Membership cancellation requires at least 48 hours before renewal; paid membership fees are described as nonrefundable
Featured provider
Oak
Oak scores 63.2/100 (C). Oak advertises compounded semaglutide from $119 and tirzepatide from $185 per month on twelve-month plans; compare the actual payment schedule and discount repayment terms before choosing a longer commitment.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.